Flatiron Health partners with MUSC to assist oncology care clinicians
Flatiron Assist has over 700 oncologist users and has been leveraged in over 90k treatment decisions
Read more...Shares of Facebook are up 5%, in after-hours trading, after the company posted second-quarter results that handily beat Wall Street expectations.
The stock has risen 0.93%. Facebook shares had gone up 2.92% or $2.02, to $71.29 a share in regular trading on Wednesday.
In the earnings report, Facebook posted revenue of $2.91 billion for the quarter, beating Wall Street's estimates of $2.81 billion. Adjusted earnings per share came in at 42 cents in the quarter, higher than the 32 cents a share that analysts had been expecting.
"We had a good second quarter," Mark Zuckerberg, Facebook founder and CEO. said in a statement. "Our community has continued to grow, and we see a lot of opportunity ahead as we connect the rest of the world."
Advertising revenue was $2.68 billion for the quarter. It increased 67% from the same quarter the year before. Mobile accounted for 62% of that revenue, up from approximately 41% of advertising revenue in the second quarter of 2013.
Revenue from payments and fees for the quarter was $234 million, a 9% increase year ro year.
GAAP net income was $791 million, a 138% increase from the $333 million for the second quarter of 2013, while non-GAAP net income for the quarter was $1.09 billion, up 124% compared to $488 million for the second quarter of 2013.
Daily active users (DAUs) were 829 million on average, an increase of 19% year-over-year, while mobile DAUs were 654 million on average, an increase of 39%.
Monthly active users (MAUs) were 1.32 billion on average, an increase of 14% year-over-year, while mobile MAUs were 1.07 billion on average, an increase of 31%.
Over the past couple of days, Facebook's stock saw modest gains, rising from $68.81 to $69.27.
For the year, the stock is up roughly 30%, rising from $54.83 to $71.29. It has also gained 330% from a year ago, when it was trading at $26.10 a share.
(Image source: inlimelight.com)
Flatiron Assist has over 700 oncologist users and has been leveraged in over 90k treatment decisions
Read more...While cancer rates increase, less than 10% of eligible patients participate in clinical studies
Read more...The company can automate tasks such as scheduling, confirmations, and triaging
Read more...